Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic Steatohepatitis
Public ClinicalTrials.gov record NCT02856555. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-0976 in Subjects With Nonalcoholic Steatohepatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the safety and tolerability of firsocostat in adults with nonalcoholic steatohepatitis (NASH).
Study identification
- NCT ID
- NCT02856555
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 127 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 7, 2016
- Primary completion
- Jul 17, 2017
- Completion
- Jul 17, 2017
- Last update posted
- Jul 23, 2020
2016 – 2017
United States locations
- U.S. sites
- 36
- U.S. states
- 17
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Coronado | California | 92118 | — |
| Not listed | Foster City | California | 94404 | — |
| Not listed | Los Angeles | California | 90036 | — |
| Not listed | Los Angeles | California | 90048 | — |
| Not listed | Rialto | California | 92377 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | San Francisco | California | 94143 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Miami | Florida | 33165 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | New Orleans | Louisiana | 70112 | — |
| Not listed | Boston | Massachusetts | 02115 | — |
| Not listed | Rochester | Minnesota | 55905 | — |
| Not listed | Kansas City | Missouri | 64131 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Statesville | North Carolina | 28677 | — |
| Not listed | Philadelphia | Pennsylvania | 19707 | — |
| Not listed | Pittsburgh | Pennsylvania | 15213 | — |
| Not listed | Germantown | Tennessee | 38138 | — |
| Not listed | Memphis | Tennessee | 38104 | — |
| Not listed | Nashville | Tennessee | 37211 | — |
| Not listed | Arlington | Texas | 76012 | — |
| Not listed | Live Oak | Texas | 78233 | — |
| Not listed | San Antonio | Texas | 78215 | — |
| Not listed | Murray | Utah | 84107 | — |
| Not listed | Falls Church | Virginia | 22042 | — |
| Not listed | Richmond | Virginia | 23226 | — |
| Not listed | Richmond | Virginia | 23249 | — |
| Not listed | Richmond | Virginia | 23298 | — |
| Not listed | Richland | Washington | 99352 | — |
| Not listed | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02856555, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2020 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02856555 live on ClinicalTrials.gov.